Mechanical and pharmacologic catheter-directed thrombolysis treatment of severe, symptomatic, bilateral deep vein thrombosis with congenital absence of the inferior vena cava  by Garg, Karan et al.
From the Eastern Vascular Society
Mechanical and pharmacologic catheter-directed
thrombolysis treatment of severe, symptomatic,
bilateral deep vein thrombosis with congenital
absence of the inferior vena cava
Karan Garg, MD, Neal Cayne, MD, and Glenn Jacobowitz, MD, New York, NY
We report the use of mechanical and pharmacologic catheter-directed thrombolysis in treating deep vein thrombosis with
congenital absence of the inferior vena cava The patient presented with disabling bilateral lower extremity swelling and
pain and was found to have extensive bilateral iliofemoral deep vein thromboses. Genetic testing revealed a factor V
Leiden mutation. The patient underwent thrombolysis using a Possis (MEDRAD Inc, Warrendale, Pa) catheter and
overnight infusion of tissue plasminogen activator. The patient tolerated the procedure well, with prompt return to daily
activities. He remains free of symptoms at 3 years on oral anticoagulation, with a patent venous architecture. ( J Vasc Surg
2011;53:1707-10.)
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tCongenital absence of the inferior vena cava (AIVC) is
a well-documented phenomenon that which may be asso-
ciated with an increased risk for deep vein thrombosis
(DVT).1 We report the first case, to our knowledge, of
DVT in a patient with AIVC treated with catheter-directed
pharmacomechanical thrombolysis to restore baseline ve-
nous drainage to alleviate symptoms.
CASE REPORT
The patient is a 25-year-old previously healthyman, a plumber
by profession, who presented with a sudden onset of debilitating
bilateral lower extremity swelling and severe thigh and calf pain.
His symptoms prevented him from ambulating. The patient had
no known developmental abnormalities, and his family history was
unremarkable. A venous and arterial duplex ultrasound scan of the
lower extremity and a computed tomography (CT) scan of the
abdomen and pelvis performed at another institution revealed
thrombus extending from the popliteal vein to the common iliac
vessels bilaterally. The IVC and right kidney were absent.
Intravenous heparin therapy was initiated and continued for 2
weeks, without improvement of symptoms. The patient was trans-
ferred to our institution for additional management. Heparin
therapy was continued and a magnetic resonance (MR) venogram
confirmed the findings seen on ultrasound imaging and the CT
scan (Fig 1). Because the patient had failed to improve on
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doi:10.1016/j.jvs.2011.02.012nticoagulation, we proceeded with pelvic and lower extremity
enography and catheter-directed thrombolysis. The goal was
o re-establish the patient’s baseline venous drainage for symp-
omatic relief and also to prevent post-thrombotic syndrome.
Ultrasound guidance was used for bilateral access of the pop-
iteal vein. Venography demonstrated thrombus extending from
he popliteal veins to the confluence of the iliac veins bilaterally
ith an AIVC (Fig 2). The venous outflow of the lower extremities
nd pelvis was through large collateral vessels that reconstituted to
supradiaphragmatic IVC.
Tissue plasminogen activator (tPA) was pulse-sprayed through-
ut the entire clot bilaterally through a Possis catheter (MEDRAD
nc,Warrendale, Pa) at 5mg/side (1mg/10mL normal saline). The
PAwas left in situ for 15minutes, after which the Possis catheter was
sed to mechanically lyse additional thrombus.
Venography demonstrated patent popliteal, femoral, and iliac
eins bilaterally. Because residual thrombus was present, the lytic
atheters were left in place bilaterally, infusing tPA at 1 mg/h per
atheter for 24 hours. Serial fibrinogen and D-dimer levels were
onitored during the infusion. A mild hemoglobinuria occurred,
hich resolved spontaneously. The patient’s renal function was unaf-
ected.
Venography after 24 hours of infusion demonstrated im-
roved patency of the venous system bilaterally. A Possis catheter
as again advanced through the residual clot, and additional
hrombolysis was performed. There was now good flow through-
ut the venous system from the popliteal veins to the iliac conflu-
nce. A large collateral branch off of the left common iliac vein also
as recanalized and contributed to improved venous drainage (Fig
). This collateral reconstituted the IVC at the level of the dia-
hragm. The patient was systematically heparinized, and the tPA
nfusion was discontinued.
Postoperatively, the patient’s symptoms gradually improved.
thrombophilia workup identified a heterozygous mutation for
actor V Leiden R506Q polymorphism. Because of the extent of
he initial thrombus, the severity of the presenting symptoms, and
he risk factor for hypercoagulability, the lifelong warfarin therapy
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June 20111708 Garg et alwas initiated. The patient has now been monitored for 36 months
postoperatively with physical examination and venous duplex ul-
trasound scans, with no recurrence of DVTs and a stable patent
lower extremity deep venous system.
DISCUSSION
AIVC commonly occurs in association with other car-
diac and visceral congenital malformations, including dex-
trocardia, atrial septal defects, asplenia, or dysgenesis of the
lungs.1-3 The derivation of the IVC has been studied ex-
Fig 1. Magnetic resonance venography demonstrates (top
panel) clot at the iliac confluence, with (middle panel) absence of
infrarenal inferior vena cava superiorly and (bottom panel) retro-
hepatic reconstitution.tensively.4-6 The IVC develops, starting at the sixth week of ambryogenesis, from three pairs of primitive veins: the
upracardinal, subcardinal, and postcardinal veins. These
eins form extensive collaterals during development, fol-
owed by regression, leaving one continuous vessel.
The IVC can be divided into four segments: hepatic,
rerenal, postrenal, and the renal collar. The supracardinal
ives rise to the postrenal IVC along with the hemiazygos
nd azygos veins. The subcardinal gives rise to the prerenal
ortion. Hepatic sinusoids form the hepatic segment, while
he renal collar is formed by the subcardinal and supracar-
inal veins.7 Debing et al7 described a schematic of the
egments of the IVC in their 1993 report. The cause of
IVC is debated: it maybe caused by embryonic dysgenesis
r by an intrauterine insult during the perinatal period.8,9
The overall incidence of DVT in a young (40 years)
ealthy patient population is low. Individuals with DVTs
sually have a predisposing risk factor, such as a genetic
bnormality causing hypercoagulability, pregnancy, neo-
lasm, prolonged immobilization, or surgery. AIVC should
e considered as a potential associated anatomic abnormal-
ty in young patients presenting with signs and symptoms of
n acute DVT without previous evidence of the risk factors,
articularly in patients with extensive clot burden, massive
ilateral lower extremity swelling, and physical examination
ndings of prominent veins over the abdomen.
In this patient cohort, in addition to the serum tests for
hrombophilia, we recommend an abdominal and pelvic
T or MR scan to evaluate abnormalities in the central
enous drainage. Anomalies of the IVC may predispose to
istal DVT because of changes in venous flow patterns.
AIVC is rare, so the exact prevalence of this condition is
nknown. Some studies suggest AIVC is the cause of DVTs
n up to 5% of young patients aged between 20 and 40.10,11
ost published reports of patients with DVTs and AIVC
ndicate that they have a concomitant hypercoagulable
tate.1 Cases of association with hyperhomocysteinemia1
nd factor V Leiden have been described.11 The association
ith renal aplasia has also been previously reported.12
Patients with AIVC lack a main conduit through which
ragmented thrombus could potentially embolize to the lung.
onsequently, the incidence of pulmonary embolism may be
ower than with patients with a normal IVC. Only one report
as described a pulmonary embolism in a patient with
IVC.13 Thus, the role of the anticoagulation in patients with
IVC is more for symptomatic relief and prevention of post-
hrombotic sequelae and recurrent DVTs.
Most patients with AIVC andDVT have beenmanaged
ithout surgical intervention or thrombolysis and have
een treated solely with anticoagulation. Systemic throm-
olytic therapy was additionally used in three patients but
as successful in only one.1,14 Several reports have been
ublished of patients with AIVC and sequelae of long-
tanding venous congestion requiring surgical bypass.15-17
hese patients did not present with acute DVT, but rather
resented with symptoms of the venous congestion and
hen failed to improve with conservative management
lone, such as external compression. Decompression of the
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 6 Garg et al 1709Fig 2. Venogram on day 1, with the patient prone, demonstrates the clot extending up to the iliac confluence.Fig 3. Venogram on day 2, with the patient prone, demonstrates restored flow up to the iliac confluence, with a large
collateral off of the left common iliac vein.
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June 20111710 Garg et alvenous outflowwith a bypass graft resulted in improvement
of the swelling and healing of leg ulcers.
Recent guidelines from the American College of Chest
Physicians recommend the use of pharmacomechanical
thrombectomy as the preferred treatment for acute iliofem-
oral DVT, citing decreased post-thrombotic morbidity.18
Comerota et al19 showed that catheter-directed pharmaco-
mechanical thrombolytic therapy resulted in improved
thrombus lysis, a decreased incidence of DVT recurrence,
improved preservation of valvular competency, and conse-
quently, a lower incidence of post-thrombotic syndrome
compared with systemic anticoagulation alone for the treat-
ment of extensive iliofemoral DVT. The major risk from
such therapy was bleeding in 5% to 10% of patients, but this
consisted primarily of hematomas at the puncture site.19
The incidence of pulmonary embolism was 1%, and no
deaths were directly attributed to catheter-directed lytic
therapy. The IVC was patent in all patients. Similar guide-
lines should be considered in patients presenting with acute
ileofemoral DVT and AIVC.
To our knowledge, this is the first case report of the use
of catheter-directed thrombolysis for the management of
lower extremity DVT with AIVC using both pharmaco-
logic and mechanical therapy. The baseline venous outflow
was successfully restored, with immediate regression of the
swelling and relief of symptoms. The patient was dis-
charged home 3 days after the procedure.
CONCLUSIONS
Most patients with AIVC andDVT have beenmanaged
without surgery and have been treated with systemic anti-
coagulation and lifelong oral anticoagulation. However, in
the presence of extensive iliofemoral thrombus, debilitating
symptoms, or failure to show rapid improvement with
noninvasive management, catheter-directed pharmaco-
mechanical thrombolysis to restore baseline venous drain-
age should be considered the intervention of choice.
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